Healthcare professionals' self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the Netherlands.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Works matching IS 01145916 AND DT 2012 AND VI 35 AND IP 11
Results: 18
1
2
Focusing on Risk Communication About Medicines.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
3
The globalization of risk and risk perception: why we need a new model of risk communication for vaccines.
- Published in:
- 2012
- By:
- Publication type:
- journal article
4
Risk perception and communication in sub-Saharan Africa.
- Published in:
- 2012
- By:
- Publication type:
- journal article
5
Risk Communication and the Pharmaceutical Industry: what is the reality?
- Published in:
- 2012
- By:
- Publication type:
- journal article
6
Protecting the people?: risk communication and the chequered history and performance of bureaucracy.
- Published in:
- 2012
- By:
- Publication type:
- journal article
7
Challenges of drug risk communications in the Philippines.
- Published in:
- 2012
- By:
- Publication type:
- journal article
8
Adverse drug reactions: when the risk becomes a reality for patients.
- Published in:
- 2012
- By:
- Publication type:
- journal article
9
Healthcare Professionals' Self-Reported Experiences and Preferences Related to Direct Healthcare Professional Communications. A Survey Conducted in the Netherlands.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 1061, doi. 10.2165/11635750-000000000-00000
- By:
- Publication type:
- Article
10
Focusing on risk communication about medicines: why now?
- Published in:
- 2012
- By:
- Publication type:
- Editorial
11
The Globalization of Risk and Risk Perception. Why We Need a New Model of Risk Communication for Vaccines.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 1053, doi. 10.2165/11635880-000000000-00000
- By:
- Publication type:
- Article
12
Risk Perception and Communication in Sub-Saharan Africa.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 1041, doi. 10.2165/11636270-000000000-00000
- By:
- Publication type:
- Article
13
Risk Communication and the Pharmaceutical Industry. What is the Reality?
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 1027, doi. 10.2165/11635220-000000000-00000
- By:
- Publication type:
- Article
14
Protecting the People? Risk Communication and the Chequered History and Performance of Bureaucracy.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 1005, doi. 10.2165/11635210-000000000-00000
- By:
- Publication type:
- Article
15
Challenges of Drug Risk Communications in the Philippines.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 995, doi. 10.2165/11635920-000000000-00000
- By:
- Publication type:
- Article
16
Good Decision Making Requires Good Communication.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 983, doi. 10.2165/11636170-000000000-00000
- By:
- Publication type:
- Article
17
Adverse Drug Reactions. When the Risk Becomes a Reality for Patients.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 977, doi. 10.2165/11636140-000000000-00000
- By:
- Publication type:
- Article
18
Focusing on Risk Communication About Medicines. Why Now?
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 971, doi. 10.2165/11640990-000000000-00000
- By:
- Publication type:
- Article